2023-06-04 19:40:30
Johnson & Johnson is no longer the most valuable pharmaceutical company in the world. The American giant was overtaken this week, by a short head, by its competitor from Indianapolis, Eli Lilly. It has a capitalization of 421 billion dollars against 406 billion for Johnson & Johnson. Five years ago, the title of Eli Lilly was trading around 85 dollars, today it is worth 436.
1685908620
#Propelled #fight #Alzheimers #obesity #Eli #Lilly #capitalization #pharma
Related posts:
Morocco is seriously behind schedule in setting up a favorable framework
Former U.S. Treasury Secretary: Fed faces dual risks of inflation and recession, U.S. interest rate ...
Less fashion, more decoration: La Redoute’s shift
Money flows into large stocks pushing Thai stocks to recover to close +12.93 points
Volkswagen: The chip crisis will continue into 2023
2023 China Economic Annual Report丨my country's industrial economy will rebound in 2023 and the infor...
Commentary on the CS demise: No more special settings for big banks
Moderator: Samsung Galaxy A15 5G will be sold in Hong Kong in January! Qianling Mosquito has OLED Ma...